The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of phosphoproteomic subtyping of gastric cancer on chemotherapy and guidance of targeted cancer therapy.
 
Hirokazu Shoji
Research Funding - Amgen (Inst); Astellas Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Takeda (Inst)
 
Hidekazu Hirano
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Fujifilm; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Teijin Pharma
Research Funding - Amgen (Inst); BeiGene (Inst); Bristol-Myers Squibb Japan (Inst); Taiho Pharmaceutical (Inst)
 
Yosui Nojima
No Relationships to Disclose
 
Daigo Gunji
No Relationships to Disclose
 
Akina Shinkura
No Relationships to Disclose
 
Satoshi Muraoka
No Relationships to Disclose
 
Yuichi Abe
No Relationships to Disclose
 
Ryohei Narumi
No Relationships to Disclose
 
Chioko Nagao
No Relationships to Disclose
 
Masahiko Aoki
No Relationships to Disclose
 
Kazutaka Obama
Honoraria - Chugai Pharmaceuticals, Miyarisan Pharmaceuticals, Ono Pharmaceuticals, Otsuka Pharmaceuticals, Taiho Pharmaceuticals, Daiichi-Sankyo Pharmaceuticals
 
Kazufumi Honda
Stock and Other Ownership Interests - Cosomil Ink
Consulting or Advisory Role - Toray Industry Ink. Cosomil Ink
Speakers' Bureau - Toray Industry Ink
Research Funding - Shimazu Corp. Toray Industry Ink (Inst)
Patents, Royalties, Other Intellectual Property - Toray Industry Ink
 
Kenji Mizuguchi
Honoraria - Otsuka, Gilead
Other Relationship - AstraZeneca
 
Takeshi Tomonaga
No Relationships to Disclose
 
Takaki Yoshikawa
Honoraria - Astellas Pharma; AstraZeneca; BMS; Chugai Pharma; Daiichi Sankyo; EA Pharma; Intuitive Surgical; Japan Blood Products Organization; Johnson & Johnson/Janssen; Lilly; Medtronic; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - MSD Oncology; TERUMO
Research Funding - Lilly
 
Ken Kato
Honoraria - BMS; Lilly; Ono Pharmaceutical
Consulting or Advisory Role - Bayer; BeiGene; MSD; Oncolys BioPharma; Ono Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb Japan; MSD; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Beigene (Inst); Chugai Pharma (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst)
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Daiichi-Sankyo; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst); Takeda (Inst)
 
JUN Adachi
Research Funding - Boehringer Ingelheim (Inst); ONO PHARMACEUTICAL (Inst); Takeda (Inst)